Encouraging and Facilitating Diverse Participation in Clinical Trials | An Empowered Patient Podcast by Karen Jagoda
Encouraging and Facilitating Diverse Participation in Clinical Trials | An Empowered Patient Podcast by Karen Jagoda
FDA: Diversity now required in clinical trials
The White House says people of color are being hit harder by diseases simply because medicines and treatments haven't effectively been tested on diverse populations.
FDA Guidance for Increasing Diversity in Clinical Research Will Soon Become Law
The latest omnibus bill includes legislation that will codify FDA guidelines for diversity in clinical trials into law. Learn more about what this means for sponsors.
Diversity Plans: Are you ready?
Diversity Plans: Are you ready? It is widely discussed that the clinical trial industry suffers from a lack of diversity in clinical trial outcomes. “Diversity” represents a wide-range of descriptions, such as race and ethnicity, sex, gender identity, age, socioeconomic status, and disability status, to name a few. The FDA has issued several sets of...